biotech
Rezdiffra is exceeding Wall Street's expectations as the MASH market takes shape
Endpoints News
May 11, 2026 · 17s listen
Listen · Endpoints News
Rezdiffra is exceeding Wall Street's expectations as the MASH market takes shape
0:00-0:17
Live · Kokoro-82M
Audio pre-rendered by Storyflo · cached + delivered from the edge
It seems there’s room for two in the MASH market. When Novo Nordisk’s blockbuster weight loss drug Wegovy won approval in August 2025 to treat the fatty liver disease, some investors thought it would put ...
Share
Send this story to anyone — or drop the embed into a blog post, Substack, Notion page. Every play sends rev-share back to Endpoints News.
Heard via Storyflo
Get audio versions of every article you read.
Pick what matters — your audio curator gets you into your daily flo.